These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31415981)

  • 1. Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.
    Xu Y; Zhang Z; Jiang X; Chen X; Wang Z; Alsulami H; Qin HL; Tang W
    Eur J Med Chem; 2019 Nov; 181():111598. PubMed ID: 31415981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors.
    Zhang Z; Min J; Chen M; Jiang X; Xu Y; Qin H; Tang W
    Eur J Med Chem; 2020 Sep; 201():112273. PubMed ID: 32569925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease.
    Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W
    ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors.
    Qiu GL; He SS; Chen SC; Li B; Wu HH; Zhang J; Tang WJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1506-1515. PubMed ID: 30284486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorosulfate-containing pyrazole heterocycles as selective BuChE inhibitors: structure-activity relationship and biological evaluation for the treatment of Alzheimer's disease.
    Li HH; Wu C; Zhang SL; Yang JG; Qin HL; Tang W
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2099-2111. PubMed ID: 35899776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.
    de Andrade P; Mantoani SP; Gonçalves Nunes PS; Magadán CR; Pérez C; Xavier DJ; Hojo ETS; Campillo NE; Martínez A; Carvalho I
    Bioorg Med Chem; 2019 Mar; 27(6):931-943. PubMed ID: 30765302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyridazinone derivatives as butyrylcholinesterase inhibitors.
    Dundar Y; Kuyrukcu O; Eren G; Senol Deniz FS; Onkol T; Orhan IE
    Bioorg Chem; 2019 Nov; 92():103304. PubMed ID: 31561108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship,
    Wu C; Zhang G; Zhang ZW; Jiang X; Zhang Z; Li H; Qin HL; Tang W
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1860-1873. PubMed ID: 34425715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
    Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
    Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
    Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.
    Dighe SN; Deora GS; De la Mora E; Nachon F; Chan S; Parat MO; Brazzolotto X; Ross BP
    J Med Chem; 2016 Aug; 59(16):7683-9. PubMed ID: 27405689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors.
    Mozaffarnia S; Teimuri-Mofrad R; Rashidi MR
    Eur J Med Chem; 2020 Apr; 191():112140. PubMed ID: 32088494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors.
    Aslam S; Zaib S; Ahmad M; Gardiner JM; Ahmad A; Hameed A; Furtmann N; Gütschow M; Bajorath J; Iqbal J
    Eur J Med Chem; 2014 May; 78():106-17. PubMed ID: 24681070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
    Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
    Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
    Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
    Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.